Allianz Asset Management GmbH purchased a new stake in Amrize Ltd (NYSE:AMRZ - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,188,111 shares of the company's stock, valued at approximately $158,530,000.
A number of other institutional investors have also recently modified their holdings of the stock. Allspring Global Investments Holdings LLC bought a new stake in shares of Amrize during the 2nd quarter worth $62,646,000. TD Asset Management Inc bought a new stake in shares of Amrize during the 2nd quarter worth $8,190,000. Generali Asset Management SPA SGR bought a new stake in shares of Amrize during the 2nd quarter worth $4,923,000. Finally, Credit Industriel ET Commercial acquired a new position in Amrize in the 2nd quarter worth about $109,000.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on AMRZ shares. Oppenheimer initiated coverage on Amrize in a research note on Tuesday, September 9th. They issued an "outperform" rating and a $62.00 price target for the company. Barclays started coverage on Amrize in a research report on Tuesday, October 7th. They issued an "equal weight" rating for the company. Weiss Ratings reiterated a "hold (c-)" rating on shares of Amrize in a research report on Wednesday, October 8th. Zacks Research raised Amrize from a "strong sell" rating to a "hold" rating in a research note on Friday, October 10th. Finally, Royal Bank Of Canada reduced their price target on Amrize from $61.00 to $54.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $57.00.
Get Our Latest Stock Report on AMRZ
Amrize Stock Performance
Shares of Amrize stock opened at $48.53 on Thursday. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $56.29. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The firm's 50-day moving average price is $50.58.
Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing the consensus estimate of $1.03 by ($0.25). The company had revenue of $3.22 billion during the quarter.
Insider Activity at Amrize
In other Amrize news, insider Mario Gross acquired 3,000 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were bought at an average cost of $49.63 per share, with a total value of $148,890.00. Following the completion of the acquisition, the insider directly owned 23,232 shares in the company, valued at $1,153,004.16. This represents a 14.83% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jaime Hill purchased 4,000 shares of the business's stock in a transaction on Friday, August 8th. The stock was purchased at an average cost of $46.40 per share, for a total transaction of $185,600.00. Following the completion of the acquisition, the insider directly owned 9,601 shares of the company's stock, valued at approximately $445,486.40. The trade was a 71.42% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 1,124,000 shares of company stock valued at $53,225,260 over the last quarter.
About Amrize
(
Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.